Tenet Healthcare (THC) Heads Into Earnings With Its Undervalued Narrative In Focus
Simply Wall St
Sun, 19 July 2026 at 6:37 pm GMT+5:30
2 min read
- THC
-2.15%
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE
Why Tenet Healthcare Stock Is Back in Focus
Tenet Healthcare (THC) is drawing investor attention after its shares fell 2.15% in the latest session, with the move coming just ahead of the company’s July 24, 2026 earnings report
The upcoming release is expected to show slight changes in earnings per share and revenue. Recent analyst estimate revisions have trimmed EPS expectations, and the stock currently carries a Zacks Rank of #3 (Hold)
With Tenet Healthcare stock now at $194.91, the 1 day share price return of 2.15% and 7 day return of 4.57% contrast with a stronger 12.95% 30 day share price return. The 1 year total shareholder return of 11.34% and very large 3 and 5 year total shareholder returns suggest longer term holders have seen stronger gains even as near term momentum has faded slightly
If Tenet Healthcare’s recent move has you reassessing opportunities in the sector, it can be useful to compare it with other healthcare related AI stocks through 39 healthcare AI stocks
Bulls point to Tenet Healthcare’s long run of strong multi year returns and a large implied discount, while bears highlight slowing revenue growth and weaker earnings. Which side does the current valuation really support?
Most Popular Narrative: 19% Undervalued
Tenet Healthcare’s most followed valuation story puts fair value at $240.60 per share, compared with the recent close of $194.91, framing the stock as materially discounted in that narrative
Tenet Healthcare is no longer just a hospital operator. It is evolving into a broader healthcare platform built around efficiency, integration, and long-term patient management. The growing importance of behavioral health strengthens that model rather than complicating it
Curious what underpins that valuation gap? The narrative leans heavily on rising outpatient volumes, higher margin service lines, and a business mix increasingly tied to behavioral care economics
Result: Fair Value of $240.60 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts
However, Tenet Healthcare’s story could be tested if annual net income, which most recently declined 9.02%, pressures margins, or if hospital operations (still US$16,157m of revenue) face reimbursement or labor headwinds
Find out about the key risks to this Tenet Healthcare narrative
